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The effect of persistent measles virus infection on c-fos protooncogene and protein kinase C (PKC-I) gene expression 
in a murine neuroblastoma cell line was studied. Overexpression f c-fos protooncogene by infected NS20Y/MS cells 
was detected when compared with uninfected NS20Y cells. The level of PKC-I-specific mRNA was increased in infected 
NS20Y/MS cells. In addition, the level of total PKC activity in these cells was also enhanced. We conclude that persistent 
measles virus infection can alter both protooncogene expression and signal transduction i  ceils of neuronal origin. 
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1. INTRODUCTION 
There are many infections in which viruses are 
not eliminated from the body but persist in the 
host for months, years or a lifetime. Persistent in- 
fections cannot by definition be acutely lethal; they 
tend to cause mild damage or disease in the host or 
produce disease only when reactivation of latent 
genomes occurs. The central nervous system (CNS) 
appears to be uniquely predisposed for the 
development of such infections. The structural 
organization, lack of a lymphatic system, intense 
cellular specialization and high metabolic re- 
quirements, may in part explain why viruses tend 
to persist in the CNS [1]. 
Among the infectious agents displaying a pro- 
pensity for establishing persistent infections of the 
CNS is measles virus. This virus has been isolated 
from patients with subacute sclerosing 
panencephalitis (SSPE) [2] and may be involved in 
the pathogenesis of other neurological disorders of 
unknown etiology, such as multiple sclerosis [3]. 
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Measles virus is capable of infecting various 
kinds of cells in culture, causing an acute lytic ef- 
fect, while resulting in nonlytic, persistent infec- 
tions of murine neuroblastoma cells or spinal cord 
cultures [4,5]. The available experimental nd 
clinical data suggest that specific interactions may 
exist between the invading measles virus and the 
CNS. The mechanism of measles virus persistence 
is unknown, but most probably involves altera- 
tions in both cell metabolism and gene expression. 
Among the genes whose expression may be poten: 
tially affected by measles virus infection are some 
protooncogenes playing an important role in 
neuronal cell differentiation a d functions [6]. For 
instance, stimulation of neuronal cells by 
neurotransmitters, nerve growth factor, phorbol 
esters or synaptic activity in most cases results in 
rapid and transient expression of the c-fos pro- 
tooncogene. Thus, the c-fos protein product is 
among the early inducible regulatory proteins yn- 
thesized in response to cell differentiation agents 
[7]. Studies on the molecular mechanism leading to 
the expression of c-fos suggest that the inductive 
signals are delivered to the DNA transcription 
machinery by different transduction pathways 
[8,9], such as phosphatidylinositol (PI)/protein 
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kinase C (PKC) which is the major transducing 
pathway in neuronal cells [10]. Activation of PKC 
by serum growth factors or phorbol esters results 
in rapid expression of the c-fos gene [11,12]. The 
present experiments were undertaken i order to 
investigate whether persistent measles virus infec- 
tion of cell lines derived from the CNS will in- 
fluence protooncogene xpression and signal 
transduction. The results indicate that both c-fos 
expression and the PKC signalling pathway of 
murine neuroblastoma cells are altered by persis- 
tent measles virus infection at several levels. 
2. MATERIALS AND METHODS 
2.1. Cells 
The mouse neuroblastoma C1300, clone NS20Y and clone 
NS20Y/MS persistently infected with the Edmonston strain of 
measles virus were used [13]. Cells were grown as loosely 
adherent monolayers inRPMI medium supplemented with 10% 
fetal calf serum (FCS), glutamine and antibiotics. 
2.2. Northern blot analysis 
Poly(A)+-enriched fractions from both cell lines were 
prepared according to [14]. Poly(A) + mRNAs were elec- 
trophoresed and blotted according to the Northern protocol 
[15] and hybridized to dCM32P-labeled nick-translated EcoRI 
plasmid fragments. The c-fos DNA probe was provided by Dr 
I. Verma [16] and the PKC-I probe by Dr I. Weinstein (Colum- 
bia University, NY) [17]. The position of the bands was deter- 
mined by autoradiography. 
Fig.1. Expression of c-fos mRNA transcripts in infected 
NS20Y/MS and uninfected NS20Y neuroblastoma cells, 
determined by Northern hybridization analysis (A). The same 
mRNA pieparations were probed with B-actin eDNA (B). Size 
markers are 18 S and 28 S ribosomal RNA. 
2.3. Preparation of cell fractions and assay of protein kinase C 
Cell monolayers were lysed in extraction buffer containing 
20 mM Tris-HC1 (pH 7.5), 0.5 mM EGTA, 1 mM PMSF, 
10/~g/ml each of leupeptin and aprotinin and 50mM 
2-mercaptoethanol. Extraction of PKC from the membrane 
pellet or whole cell homogenates was performed in the same 
buffer with 1% Triton X-100. After sedimentation at 30000 × 
g for 30 min, cytosolic fractions or whole cell extracts were 
purified by DEAE chromatography and used for measurements 
of PKC activity [18,19]. 
3. RESULTS 
Expression of the c-fos protooncogene in both 
cell clones was studied. The results (fig.l) clearly 
show that the virus-infected cells (NS20Y/MS) ex- 
pressed considerably higher levels of c-fos mRNA 
than did uninfected NS20Y cells. 
When total enzymatic PKC activity was 
measured in the extracts of NS20Y/MS or 
uninfected NS20Y cells, it appeared that per, 
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Fig.2. Expression of PKC-I specific mRNA (A) and total PKC 
activity (B) as detected by Northern analysis in infected 
NS20Y/MS and uninfected NS20Y/MS cell clones. Histograms 
represent mean of 6 experiments _+SE. 
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Table 1 
PKC activity in persistently measles-infected neuroblastoma 
cells (pmol/min per mg protein) 
Cell fraction NS20Y NS20Y/MS Increase 
(070) 
Cytosolic 298 _+ 76 a (55%) b 469 + 91 (60070) 57.3 
Particulate 240 _+ 125 (45070) 316 =t 155 (40070) 31.6 
a SE 
b 070 of total PKC activity 
Neuroblastoma cells (5 x 107) were fractionated as described in 
section 2. Cell fractions were chromatographed on DE52 
cellulose columns (0.9 × 2 cm) and the PKC activity determined 
in 50-/~1 aliquots (0.5-0.8 mg/ml protein) 
sistently infected cells showed a 50070 increase in 
PKC activity vs uninfected cells (fig.2B). Deter- 
mination of the PKC activity in cytosolic and par- 
ticulate fractions revealed that the increase was 
almost equally distributed between both fractions, 
being slightly higher in the cytosolic fraction (table 
1). The subcellular distribution of PKC activity ex- 
pressed as the cytosolic/particulate ratio was prac- 
tically unchanged. 
We next analyzed the level of PKC mRNA in 
both cell lines. Northern blotting experiments u - 
ing poly(A)÷-enriched mRNA and specific PKC-I 
probe demonstrated that the infected clone, 
NS20Y/MS, expressed an elevated level of PKC-I 
mRNA transcripts which correlated well with the 
greater PKC activity in these cells (fig.2A). 
4. DISCUSSION 
Viral diseases in man are frequently complicated 
by viral infections of the CNS. The CNS represents 
a unique site for the establishment of such infec- 
tions because of its anatomical and functional 
characteristics [1]. Many viral diseases are 
characterized as neurological disorders (Kuru, 
Creutzfeld-Jacob disease, SSPE, progressive 
rubella, panencephalitis, etc.) [20] and it has 
recently been shown that neurons are the first 
target for HIV infection and that neurological 
symptoms appear before the immunodeficiency 
syndrome [21]. 
Here, we showed that persistent measles infec- 
tion resulted in the alteration of two important 
molecular events in cells of neuronal origin, c-fos 
protooncogene xpression and PKC-associated 
signal transduction. Our results suggest that 
measles virus is capable of up-regulating c-fos and 
PKC gene transcription. Measles virus was not 
shown to integrate into the host cell genome. In- 
stead, persistently infected cells contain large 
amounts of the viral nucleoprotein matrices and 
other viral proteins [4]. The effect of accumulated 
measles viral proteins on cell metabolism and func- 
tion remains unknown. One may speculate that it 
might result in the trans activation of PKC or c-fos 
genes [22] by some viral proteins acting on 
regulatory elements of these genes. Alternatively, 
the accumulation f viral proteins in the cytoplasm 
and nucleus may alter the turnover of PKC and c- 
fos mRNAs. In any case, the overproduction of
PKC may be compensatory to the infected cell by 
increasing its responsiveness to regulatory signals, 
mostly acting through the PI/PKC pathway. The 
alterations in signal transduction pathways caused 
by measles virus may be a general phenomenon, 
since alteration in the cAMP-dependent signalling 
pathway has also been reported for measles-virus 
infected rat glioma cells [26]. The increase in c-fos 
protooncogene expression may or may not cor- 
relate with the increase in PKC activity, since at 
least one more pathway involving adenylate 
cyclase was reported [9]. The c-fos protein product 
is a nuclear DNA-binding phosphoprotein which 
binds to the regulatory sequences of the responsive 
genes [24,25]. Binding of the known transcription 
factors to the same regions on DNA suggests that 
the c-fos gene product acts as a transcriptional 
regulator. Under normal physiological conditions, 
it is rapidly turned off, triggering the transcription 
of later genes, c-fos has been directly implicated in 
normal metabolic functions uch as cell growth, 
differentiation a d function. However, the normal 
c-fos gene product ransforms fibroblasts in vitro 
when the regulation of the fos gene is broken [7]. 
It has also been shown that a wide variety of 
human tumors contain high amounts of the c-fos 
mRNA. In addition, an increase of c-fos mRNA in 
acutely infected quiescent BALB/C 3T3 mouse 
cells by polyoma virus was reported [26]. 
Our results demonstrate hat in persistently in- 
fected cells, the c-fos gene is expressed in large 
quantities compared to uninfected cells. Consider- 
ing the enormous variety of human diseases of 
unknown etiologies, it is tempting to speculate that 
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some are caused by deregulation i gene expression 
and signal transduct ion as a result of a persistent 
virus infection. If  such deregulated activity of the 
c-fos gene or other pivotal genes is observed in ad- 
dit ional persistently virus infected cells of CNS 
origin, both in vitro and in vivo, it may help to 
delineate some of the currently unknown 
mechanisms by which such infections may impair 
the normal  physiological functions of a neural cell. 
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